Recent Analysts’ Ratings Changes for HCA Healthcare (HCA)

HCA Healthcare (NYSE: HCA) has recently received a number of price target changes and ratings updates:

• 5/4/2026 – HCA Healthcare had its price target lowered by Argus from $560.00 to $500.00. They now have a “buy” rating on the stock.
• 5/2/2026 – HCA Healthcare was downgraded by Wall Street Zen from “buy” to “hold”.
• 4/28/2026 – HCA Healthcare had its price target lowered by Sanford C. Bernstein from $541.00 to $503.00. They now have a “market perform” rating on the stock.
• 4/28/2026 – HCA Healthcare had its price target lowered by Deutsche Bank Aktiengesellschaft from $558.00 to $540.00. They now have a “buy” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Wells Fargo & Company from $481.00 to $436.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by KeyCorp from $550.00 to $510.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Barclays PLC from $551.00 to $496.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Stephens from $560.00 to $530.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Oppenheimer Holdings, Inc. from $540.00 to $520.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by TD Cowen from $561.00 to $500.00. They now have a “buy” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Leerink Partners from $573.00 to $500.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Royal Bank Of Canada from $593.00 to $534.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Truist Financial Corporation from $546.00 to $535.00. They now have a “buy” rating on the stock.
• 4/24/2026 – HCA Healthcare had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $525.00 price target on the stock.
• 4/15/2026 – HCA Healthcare had its price target lowered by Robert W. Baird from $450.00 to $442.00. They now have a “neutral” rating on the stock.
• 3/27/2026 – HCA Healthcare had its “buy (b)” rating reaffirmed by Weiss Ratings.
• 3/10/2026 – HCA Healthcare had its price target raised by TD Cowen from $529.00 to $561.00. They now have a “buy” rating on the stock.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Insider Activity

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 13,714 shares of company stock worth $7,050,460. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.